Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1
Articolo
Data di Pubblicazione:
2019
Citazione:
Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1 / Reinisch, W; Bressler, B; Curtis, R; Parikh, A; Yang, H; Rosario, M; Roseth, A; Danese, S; Feagan, B; Sands, Be; Ginsburg, P; Dassopoulos, T; Lewis, J; Xu, J; Wyant, T. - In: INFLAMMATORY BOWEL DISEASES. - ISSN 1078-0998. - 25:4(2019), pp. 803-810. [10.1093/ibd/izy304]
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Reinisch, W; Bressler, B; Curtis, R; Parikh, A; Yang, H; Rosario, M; Roseth, A; Danese, S; Feagan, B; Sands, Be; Ginsburg, P; Dassopoulos, T; Lewis, J; Xu, J; Wyant, T
Link alla scheda completa:
Pubblicato in: